SEONGWON SHIN

Dr. SEONGWON SHIN

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2026 in Genes
Verified
Journal Article
Open access
PDF file
SSSEONGWON SHIN
SEONGWON SHIN
CJChi Young Jung
Chi Young Jung
MHMi Jeong Hong
Mi Jeong Hong
JLJang Hyuck Lee
Jang Hyuck Lee
WLWon Kee Lee
Won Kee Lee
JCJin Eun Choi
Jin Eun Choi
Background/Objectives: Genetic variation in components of the ubiquitin–proteasome system may contribute to cancer progression and clinical outcomes. This study investigated whether potentially functional variants in E3 ubiquitin ligase-related genes are associated with survival outcomes after surgical resection of non-small cell lung cancer (NSCLC). Methods: The study included 744 Korean patients with stage I–IIIA NSCLC, divided into discovery and validation cohorts. Fifty-one potentially functional single-nucleotide polymorphisms in E3 ubiquitin ligase-related genes were evaluated for associations with overall survival (OS) and disease-free survival (DFS). Results: Among the polymorphisms examined, BTRC rs10883617 T>C was significantly associated with DFS in the validation cohort, whereas the association with OS showed a concordant trend but did not reach statistical significance. In the combined cohort, carriers of at least one C allele had significantly better OS (HR = 0.55, 95% CI = 0.34–0.90, p = 0.02) and DFS (HR = 0.64, 95% CI = 0.46–0.89, p = 0.01) than patients with the TT genotype. The C allele demonstrated significantly lower promoter activity than the T allele in A549 and H1299 lung cancer cell lines (both p < 0.01). BTRC mRNA expression was significantly higher in tumor tissues than in paired non-neoplastic tissues (p < 0.001), but did not differ by genotype. Conclusions: Collectively, BTRC rs10883617 T>C was associated with favorable survival outcomes and allele-specific promoter activity in surgically resected NSCLC. However, its effect on endogenous BTRC expression remains unconfirmed in this patient population. Independent external validation and further mechanistic studies are warranted.

9 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SSSEONGWON SHIN
SEONGWON SHIN
CJChi Young Jung
Chi Young Jung
CKChang Ho Kim
Chang Ho Kim
JLJaehee Lee
Jaehee Lee
Background: Tuberculous pleural effusion (TPE) occasionally presents with polymorphonuclear leukocyte (PMN)-predominant pleural fluid (PF) and elevated serum C-reactive protein (CRP), mimicking parapneumonic effusion (PPE). We investigated factors distinguishing TPE from PPE in this diagnostically challenging setting. Methods: We retrospectively reviewed consecutive patients with confirmed TPE or PPE at a tertiary referral center (2010–2024). Patients with serum CRP ≥ 10 mg/dL were classified according to PF PMN-predominance. Independent discriminators between PMN-predominant TPE and PPE were identified using multivariable Firth logistic regression. Results: Among 414 patients with confirmed TPE, 108 (26%) had serum CRP ≥ 10 mg/dL, including 20 with PMN-predominance and 88 without. Anti-tuberculosis treatment was modestly delayed in the PMN-predominant group (p = 0.017). These 20 patients were compared with 335 PPE patients showing the same CRP/PMN profile. Pulmonary nodular lesions on chest computed tomography and PF adenosine deaminase (ADA) were independent discriminators. A composite two-tier rule—nodular lesions present or PF ADA > 80 IU/L if absent—achieved an AUROC of 0.925, 80.0% sensitivity, and 86.2% specificity. Conclusions: In patients with PMN-predominant pleural effusion and elevated serum CRP, this simple, readily available rule may help identify patients warranting early pleural biopsy and heightened suspicion for TPE before microbiological confirmation.